[#item_full_content] Product developed and manufactured by MediPharm Labs is now available by prescription through Brazilian pharmaciesTORONTO, Nov. 10, 2026 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or the “Company”), is pleased to announce the commercial launch of a full-spectrum CBD oral oil in Brazil through its pharmaceutical partner, Alko do Brasil Indústria e Comércio Ltda, “Alko”. MediPharm manufactures the product at its pharmaceutical faci  Read More